UniProt/SwissProt ID: | ACTB_HUMAN |
Description: | actin, beta [Source:HGNC Symbol;Acc:132] |
Location: | chr7 p22.1 |
Node attribute: | gene |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
S60 | GDEAQsKRGIL | Actin | PhosphoSitePlus |
T194 | LMKILtERGYS | Actin | PhosphoSitePlus |
T201 | RGYSFtTTAER | Actin | PhosphoSitePlus |
Y198 | LTERGySFTTT | phosphoELM | |
T89 | KIWHHtFYNEL | Actin | PhosphoSitePlus |
Y166 | HTVPIyEGYAL | Actin | PhosphoSitePlus |
T318 | MQKEItALAPS | Actin | PhosphoSitePlus; SysPTM |
T120 | NREKMtQIMFE | Actin | PhosphoSitePlus |
Y188 | RDLTDyLMKIL | Actin | PhosphoSitePlus |
Y362 | ISKQEyDESGP | Actin | PhosphoSitePlus |
Y53 | GQKDSyVGDEA | phosphoELM | |
Y218 | KEKLCyVALDF | HPRD; phosphoELM | |
S368 | DESGPsIVHRK | Actin | PhosphoSitePlus |
S271 | FLGMEsCGIHE | Actin | PhosphoSitePlus |
S52 | MGQKDsYVGDE | Actin | PhosphoSitePlus |
S365 | QEYDEsGPSIV | Actin | PhosphoSitePlus |
T201 | RGYSFtTTAER | HPRD | |
Y240 | SLEKSyELPDG | Actin | PhosphoSitePlus |
Y306 | GGTTMyPGIAD | Actin | PhosphoSitePlus |
S155 | GIVMDsGDGVT | Actin | PhosphoSitePlus |
T202 | GYSFTtTAERE | Actin | PhosphoSitePlus |
Y294 | IRKDLyANTVL | Actin | PhosphoSitePlus |
Y91 | WHHTFyNELRV | Actin | PhosphoSitePlus |
S199 | TERGYsFTTTA | Actin | PhosphoSitePlus |
T304 | LSGGTtMYPGI | Actin | PhosphoSitePlus |
T249 | DGQVItIGNER | Actin | PhosphoSitePlus |
T303 | VLSGGtTMYPG | Actin | PhosphoSitePlus |
S323 | TALAPsTMKIK | Actin | PhosphoSitePlus |
T186 | AGRDLtDYLMK | Actin | PhosphoSitePlus |
Y294 | IRKDLyANTVL | HPRD; phosphoELM | |
S33 | RAVFPsIVGRP | Actin | PhosphoSitePlus |
Y198 | LTERGySFTTT | Actin | PhosphoSitePlus |
S239 | SSLEKsYELPD | Actin | PhosphoSitePlus |
T318 | MQKEItALAPS | HPRD; phosphoELM; SysPTM | |
Y218 | KEKLCyVALDF | Actin | PhosphoSitePlus |
Y91 | WHHTFyNELRV | phosphoELM | |
T324 | ALAPStMKIKI | Actin | PhosphoSitePlus |
T203 | YSFTTtAEREI | Actin | PhosphoSitePlus |
Y143 | AVLSLyASGRT | Actin | PhosphoSitePlus |
S265 | ALFQPsFLGME | Actin | PhosphoSitePlus |
S14 | VVDNGsGMCKA | Actin | PhosphoSitePlus |
Y69 | ILTLKyPIEHG | Actin | PhosphoSitePlus |
Y169 | PIYEGyALPHA | Actin | PhosphoSitePlus |
Y53 | GQKDSyVGDEA | Actin | PhosphoSitePlus |
S14 | VVDNGsGMCKA | HPRD | |
S300 | ANTVLsGGTTM | Actin | PhosphoSitePlus |
S348 | GSILAsLSTFQ | Actin | PhosphoSitePlus |
Y306 | GGTTMyPGIAD | HPRD | |
Dephosphorylation site |
ACTB_HUMAN do not have dephosphorylation site. |
Mutation site |
ACTB_HUMAN do not have mutation site. |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000349960 | hepatitis B virus | Normal vs. Cancer | tissue | Down | 0.47 | 14726492 |
ENSP00000349960 | colorectal cancer | Normal vs. Cancer | tissue | Up | 3.5 | 19098285 |
ENSP00000349960 | colorectal cancer | Normal vs. Cancer | tissue | Up | 1.4 | 15924290 |
ENSP00000349960 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Down | 0.05 | 15759316 |
ENSP00000349960 | papillary thyroid carcinoma | Normal vs. Cancer | tissue | Down | 0.23 | 16788983 |
ENSP00000349960 | follicular thyroid carcinoma | Normal vs. Cancer | tissue | Down | 0.49 | 18316623 |
ENSP00000349960 | follicular thyroid carcinoma | Normal vs. Cancer | tissue | Down | 0.56 | 18316623 |
ENSP00000349960 | follicular thyroid carcinoma | Normal vs. Cancer | tissue | Up | 1.2 | 18316623 |
ENSP00000349960 | follicular thyroid carcinoma | Normal vs. Cancer | tissue | Up | 1.3 | 18316623 |
ENSP00000349960 | papillary thyroid carcinoma | Normal vs. Cancer | tissue | Up | 1.5 | 18665625 |
ENSP00000349960 | papillary thyroid carcinoma | Normal vs. Cancer | tissue | Up | 2.6 | 18665625 |
ENSP00000349960 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.2 | 19072117 |
ENSP00000349960 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.6 | 19072117 |
ENSP00000349960 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Down | 0.86 | 19072117 |
ENSP00000349960 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.4 | 19072117 |
ENSP00000349960 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Down | 0.92 | 19072117 |
ENSP00000349960 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.1 | 19072117 |
ENSP00000349960 | Esophageal Cancer | Normal vs. Cancer | tissue | Down | 0.41 | 19142970 |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | cell line | Up | 2 | 14997480 |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | cell line | Up | 2.5 | 14997480 |
ENSP00000349960 | Hepatocellular Carcinoma | Cancer vs. Cancer (HCC vs. HuCCA) | cell line | Up | 20069059 | |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | tissue | Up | >10 | 20005186 |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | cell line | Up | 2.2 | 20052998 |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | cell line | Up | 2.6 | 20052998 |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | cell line | Down | 0.96 | 20052998 |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.2 | 20052998 |
ENSP00000349960 | Breast Cancer | Metastasis | cell line | Down | 0.44 | 20052998 |
ENSP00000349960 | Breast Cancer | Metastasis | cell line | Down | 0.47 | 20052998 |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | tissue | Up | 2.4 | 20087651 |
ENSP00000349960 | Breast Cancer | Normal vs. Cancer | tissue | Up | 2.9 | 20087651 |
ENSP00000349960 | Neoplasms by Histologic Type | Cancer vs. Cancer (ER- vs ER+) | tissue | Up | 1.6 | 20602252 |
ENSP00000349960 | Oral Cancer | Normal vs. Cancer | tissue | Up | 5.9 | 19691830 |
ENSP00000349960 | chronic myeloid leukemia | Treatment (Imatinib-sensitive vs. Imatinib-resistant) | cell line | Up | 1.4 | 20417730 |
ENSP00000349960 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Up | 3.9 | 17655343 |
ENSP00000349960 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Up | 5.1 | 17655343 |
ENSP00000349960 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Up | 7.5 | 17655343 |
ENSP00000349960 | acute myeloid leukemia | Treatment (none vs. NSC606985 treatment) | cell line | Down | 17655343 | |
ENSP00000349960 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 3 hour) | cell line | Up | 2.5 | 15169874 |
ENSP00000349960 | Neoplasms by Histologic Type | Cancer vs. Cancer (subtype) | tissue | Down | 0.22 | 16807943 |
ENSP00000349960 | Neoplasms by Histologic Type | Cancer vs. Cancer (subtype) | tissue | Up | 2 | 16807943 |
ENSP00000349960 | Neoplasms by Histologic Type | Cancer vs. Cancer (subtype) | tissue | Down | 0.56 | 16807943 |
ENSP00000349960 | Neoplasms by Histologic Type | Cancer vs. Cancer (subtype) | tissue | Up | 1.6 | 16807943 |
ENSP00000349960 | Pancreatic Cancer | Normal vs. Cancer | tissue | Up | 4.2 | 16230073 |
ENSP00000349960 | Uterine Cancer | Treatment(none vs. transfected with the pOP13 vector that containing E7) | cell line | Down | 14997504 | |
ENSP00000349960 | Uterine Cancer | Treatment (Concurrent chemoradiotherapy-lowly vs. Concurrent chemoradiotherapy-highly sensitive) | tissue | Up | 19507834 | |
Hyperphosphorylation site |
ACTB_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
SRF_HUMAN | ACTB_HUMAN | TF -> target gene | TRANSFAC |
ELK1_HUMAN | ACTB_HUMAN | TF -> target gene | TRANSFAC |
ELK4_HUMAN | ACTB_HUMAN | TF -> target gene | TRANSFAC |
Function Annotation |
KEGG Pathway |
ACTB_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0005856 | cytoskeleton | TAS | cellular_component |
GO:0005829 | cytosol | IEA | cellular_component |
GO:0006928 | cellular component movement | TAS | biological_process |
GO:0030424 | axon | IEA | cellular_component |
GO:0070062 | extracellular vesicular exosome | IDA | cellular_component |
GO:0006457 | protein folding | TAS | biological_process |
GO:0044267 | cellular protein metabolic process | TAS | biological_process |
GO:0007411 | axon guidance | TAS | biological_process |
GO:0007409 | axonogenesis | IEA | biological_process |
GO:0051084 | 'de novo' posttranslational protein folding | TAS | biological_process |
GO:0014069 | postsynaptic density | IEA | cellular_component |
GO:0030529 | ribonucleoprotein complex | IDA | cellular_component |
GO:0007596 | blood coagulation | TAS | biological_process |
GO:0034332 | adherens junction organization | TAS | biological_process |
GO:0045216 | cell-cell junction organization | TAS | biological_process |
GO:0030957 | Tat protein binding | IPI | molecular_function |
GO:0070688 | MLL5-L complex | IDA | cellular_component |
GO:0030863 | cortical cytoskeleton | IEA | cellular_component |
GO:0019901 | protein kinase binding | IEA | molecular_function |
GO:0034329 | cell junction assembly | TAS | biological_process |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0005200 | structural constituent of cytoskeleton | TAS | molecular_function |
GO:0019894 | kinesin binding | IPI | molecular_function |
GO:0050998 | nitric-oxide synthase binding | IPI | molecular_function |
GO:0005737 | cytoplasm | TAS | cellular_component |
GO:0035267 | NuA4 histone acetyltransferase complex | IDA | cellular_component |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0043234 | protein complex | IEA | cellular_component |